Joint op in Hanumangarh leads to seizure of controlled drug used as intoxicant

Jaipur: A joint operation by drug control officers and Hanumangarh police Monday led to the seizure of 13,400 capsules containing Pregabalin, a controlled compound used in the treatment of nerve-related conditions. Two people were arrested in this connection.

An official of the Food Safety and Drug Control Commissionerate said both accused were selling these drugs illegally for use as intoxicants. The value of the seized drugs was reported to be Rs 2.3 lakh.

Pregabalin is commonly used for the treatment of neurological pain, epilepsy and anxiety disorder, and comes with a range of side effects, including depression, fatigue, weight gain, muscle pain and heart disease, the official said.

State drug controller (I) Ajay Phatak said that Monday’s seizure was part of efforts to curb drug trafficking and narcotic activities across the state. All assistant drug controllers and drug control officers in the state have been directed to intensify operations against trafficking in collaboration with the police, he added.

Phatak also appealed to the public for any information they could share relating to the illegal trade of banned drugs and narcotics.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre